PlainRecalls
FDA Devices Low Class III Ongoing

In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-020;

Reported: March 6, 2024 Initiated: February 1, 2024 #Z-1188-2024

Product Description

In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-020;

Reason for Recall

Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.

Details

Recalling Firm
Abbott Molecular, Inc.
Units Affected
16 kits
Distribution
US Nationwide distribution in the states of AL, CA, IL, MA, MD, MN, NY, and PA.
Location
Des Plaines, IL

Frequently Asked Questions

What product was recalled?
In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-020;. Recalled by Abbott Molecular, Inc.. Units affected: 16 kits.
Why was this product recalled?
Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 6, 2024. Severity: Low. Recall number: Z-1188-2024.